Merck Sharp & Dohme Corp.'s Net Worth

$1.18 Billion

Estimate Recalculated Feb 7, 2024 03:55PM EST

Who is Merck Sharp & Dohme Corp.?

Merck Sharp & Dohme Corp. has an estimated net worth of $1.18 Billion. This is based on reported shares across multiple companies, which include OPGEN INC, BeiGene, Ltd., ARQULE INC, NGM BIOPHARMACEUTICALS INC, SUTRO BIOPHARMA INC, and Menlo Therapeutics Inc..

SEC CIK

Merck Sharp & Dohme Corp.'s CIK is 0000942443

Past Insider Trading and Trends

2016 was Merck Sharp & Dohme Corp.'s most active year for acquiring shares with 8 total transactions. Merck Sharp & Dohme Corp.'s most active month to acquire stocks was the month of January. 2016 was Merck Sharp & Dohme Corp.'s most active year for disposing of shares, totalling 2 transactions. Merck Sharp & Dohme Corp.'s most active month to dispose stocks was the month of January. 2019 saw Merck Sharp & Dohme Corp. paying a total of $65,946,928.00 for 12,955,016 shares, this is the most they've acquired in one year. In 2018 Merck Sharp & Dohme Corp. cashed out on 74,794,315 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OPGEN INC (OPGN) Snapshot price: $0.36

Investor

Merck Sharp & Dohme Corp. owns 5,413,449 units of Common Stock which is worth $1,948,841.64. In the year 2015 Merck Sharp & Dohme Corp. acquired a total of 3,934,427 shares in OPGEN INC.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+102.07%
2.73M
5.41M
Jun 27
Form 4
+81.13%
1.2M
2.68M
May 19
Form 3
0
0
No matching records found

BeiGene, Ltd. (BGNE) Snapshot price: $153.58

Investor

Merck Sharp & Dohme Corp. owns 7,942,314 units of Ordinary Shares which is worth $1,219,780,584.12. In the year 2016 Merck Sharp & Dohme Corp. filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
31.59M
31.59M
Feb 8
Form 3
0
0
No matching records found

ARQULE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

NGM BIOPHARMACEUTICALS INC (NGM) Snapshot price: $1.42

Investor

Merck Sharp & Dohme Corp. owns 12,955,016 units of Common Stock which is worth $18,396,122.72. In the year 2019 Merck Sharp & Dohme Corp. filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
12.96M
$16.00
12.96M
Apr 8
Form 3
0
0
No matching records found

SUTRO BIOPHARMA INC (STRO) Snapshot price: $4.685

Investor

Merck Sharp & Dohme Corp. owns 2,723,509 units of Common Stock which is worth $12,759,639.67. In the year 2018 Merck Sharp & Dohme Corp. filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.72M
$15.00
2.72M
Oct 1
Form 3
0
0
No matching records found